Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndrome.
R N Husson, L A Ross, S Sandelli...
https://pubmed.ncbi.nlm.nih.gov/8176574Completed
Led by Abbott · Updated on 2008-08-04
24
Participants Needed
2
Research Sites
N/A
Total Duration
A
Abbott
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
To evaluate three doses of clarithromycin in children with AIDS and Mycobacterium avium complex (MAC) infection who are receiving concurrent antiretroviral therapy. Before more extensive evaluation of this promising drug for treatment of MAC infection in children can be done, it is important to study the pharmacokinetics of this drug in this population, to get information regarding its use in pediatric patients receiving currently available antiretroviral drugs, and to get information on the antimycobacterial activity of this drug.
CONDITIONS
The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDS
You may qualify if you...
Inclusion Criteria
Concurrent Medication:
Allowed:
Prior Medication: Required:
Patients must have the following:
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
Patients with the following are excluded:
Prior Medication:
Excluded within 30 days of study entry:
Active alcohol or drug use sufficient in the opinion of the investigator to prevent adequate compliance with medication regimen and clinic visits.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 2 locations
1
Children's Hosp of Los Angeles
Los Angeles, California, United States, 90027
Status Unknown
2
Natl Cancer Institute / HIV / AIDS Malignancy Branch
Bethesda, Maryland, United States, 20892
Status Unknown
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
R N Husson, L A Ross, S Sandelli...
https://pubmed.ncbi.nlm.nih.gov/8176574